NEW YORK (GenomeWeb) – MDxHealth today announced a partnership with SouthGenetics to market its ConfirmMDx test for prostate cancer in Latin America.

Under the terms of the agreement, Montevideo, Uruguay-based SouthGenetics secures rights to commercialize ConfirmMDx for Prostate Cancer in Argentina, Bolivia, Chile, Colombia, the Dominican Republic, Ecuador, Mexico, Peru, Panama, Paraguay, Uruguay, and Venezuela. Financial and other details of the agreement were not disclosed.

All tests will be processed at MDxHealth's CLIA-certified laboratory in Irvine, California.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.